Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

8.91

+0.31 (3.60%)

At close: Feb 27, 2026, 4:00 PM EST

8.86

-0.05 (-0.56%)

After-hours: Feb 27, 2026, 7:59 PM EST

Vanda Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	216.11	198.77	192.64	254.38	268.68
Revenue Growth (YoY)	8.72%	3.18%	-24.27%	-5.32%	8.27%
Cost of Revenue	13.04	11.31	14.8	24.28	25.63
Gross Profit	203.06	187.46	177.84	230.1	243.05
Selling, General & Admin	237.95	146.41	112.88	136.49	124.05
Research & Development	109.27	74.43	76.82	85.77	75.36
Amortization of Goodwill & Intangibles	7.01	7.27	2.09	1.52	1.48
Operating Expenses	354.23	228.12	191.8	223.77	200.89
Operating Income	-151.17	-40.66	-13.95	6.33	42.17
Interest & Investment Income	10.47	10.75	-	-	-
Other Non Operating Income (Expenses)	-	-	11.49	2.01	1.85
EBT Excluding Unusual Items	-140.7	-29.92	-2.46	8.34	44.01
Gain (Loss) on Sale of Investments	2.05	6.99	8.8	2.96	-1.65
Pretax Income	-138.65	-22.92	6.34	11.3	42.36
Income Tax Expense	81.83	-4.02	3.83	5.03	9.21
Net Income	-220.47	-18.9	2.51	6.28	33.15
Net Income to Common	-220.47	-18.9	2.51	6.28	33.15
Net Income Growth	-	-	-60.02%	-81.07%	42.06%
Shares Outstanding (Basic)	59	58	57	56	56
Shares Outstanding (Diluted)	59	58	58	57	57
Shares Change (YoY)	1.34%	1.03%	1.01%	0.11%	3.14%
EPS (Basic)	-3.74	-0.33	0.04	0.11	0.60
EPS (Diluted)	-3.74	-0.33	0.04	0.11	0.58
EPS Growth	-	-	-63.64%	-81.03%	38.09%
Free Cash Flow	-110.44	-20.48	-88.25	31.31	63.66
Free Cash Flow Per Share	-1.87	-0.35	-1.53	0.55	1.12
Gross Margin	93.96%	94.31%	92.32%	90.45%	90.46%
Operating Margin	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Profit Margin	-102.02%	-9.51%	1.30%	2.47%	12.34%
Free Cash Flow Margin	-51.11%	-10.30%	-45.81%	12.31%	23.69%
EBITDA	-143.06	-32.53	-10.94	9.06	45.01
EBITDA Margin	-66.20%	-16.36%	-5.68%	3.56%	16.75%
D&A For EBITDA	8.11	8.13	3.01	2.73	2.84
EBIT	-151.17	-40.66	-13.95	6.33	42.17
EBIT Margin	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Effective Tax Rate	-	-	60.42%	44.47%	21.75%
Revenue as Reported	216.11	198.77	192.64	254.38	268.68

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q